Cargando…

CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection

Staphylococcus xylosus (S. xylosus)‐induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat S. xylosus infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Si‐Di, Zhang, Zhi‐Yun, Ma, Jin‐Xin, Qu, Qian‐Wei, God'spowe, Bello‐Onaghise, Qin, Yue, Chen, Xue‐Ying, Li, LU, Zhou, Dong‐Fang, Ding, Wen‐Ya, Li, Yan‐Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867972/
https://www.ncbi.nlm.nih.gov/pubmed/34180582
http://dx.doi.org/10.1111/1751-7915.13870
_version_ 1784656154036535296
author Zheng, Si‐Di
Zhang, Zhi‐Yun
Ma, Jin‐Xin
Qu, Qian‐Wei
God'spowe, Bello‐Onaghise
Qin, Yue
Chen, Xue‐Ying
Li, LU
Zhou, Dong‐Fang
Ding, Wen‐Ya
Li, Yan‐Hua
author_facet Zheng, Si‐Di
Zhang, Zhi‐Yun
Ma, Jin‐Xin
Qu, Qian‐Wei
God'spowe, Bello‐Onaghise
Qin, Yue
Chen, Xue‐Ying
Li, LU
Zhou, Dong‐Fang
Ding, Wen‐Ya
Li, Yan‐Hua
author_sort Zheng, Si‐Di
collection PubMed
description Staphylococcus xylosus (S. xylosus)‐induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat S. xylosus infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic treatments. In this study, we developed ceftiofur‐loaded chitosan grafted with β‐cyclodextrins (CD‐g‐CS) nanoparticles (CT‐NPs) using host–guest interaction. These positively charged nanoparticles improved bacterial internalization, thereby significantly improving the effectiveness of antibacterial treatments for planktonic S. xylosus. Moreover, CT‐NPs effectively inhibited biofilm formation and eradicated mature biofilms. After mammary injection in a murine model of S. xylosus‐induced mastitis, CT‐NPs significantly reduced bacterial burden and alleviated inflammation, thereby achieving optimized therapeutic efficiency for S. xylosus infection. In conclusion, this treatment strategy could improve the efficiency of antibiotic therapeutics and shows great potential in the treatment of S. xylosus infections.
format Online
Article
Text
id pubmed-8867972
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88679722022-02-28 CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection Zheng, Si‐Di Zhang, Zhi‐Yun Ma, Jin‐Xin Qu, Qian‐Wei God'spowe, Bello‐Onaghise Qin, Yue Chen, Xue‐Ying Li, LU Zhou, Dong‐Fang Ding, Wen‐Ya Li, Yan‐Hua Microb Biotechnol Research Articles Staphylococcus xylosus (S. xylosus)‐induced cow mastitis is an extremely serious clinical problem. However, antibiotic therapy does not successfully treat S. xylosus infection because these bacteria possess a strong biofilm formation ability, which significantly reduces the efficacy of antibiotic treatments. In this study, we developed ceftiofur‐loaded chitosan grafted with β‐cyclodextrins (CD‐g‐CS) nanoparticles (CT‐NPs) using host–guest interaction. These positively charged nanoparticles improved bacterial internalization, thereby significantly improving the effectiveness of antibacterial treatments for planktonic S. xylosus. Moreover, CT‐NPs effectively inhibited biofilm formation and eradicated mature biofilms. After mammary injection in a murine model of S. xylosus‐induced mastitis, CT‐NPs significantly reduced bacterial burden and alleviated inflammation, thereby achieving optimized therapeutic efficiency for S. xylosus infection. In conclusion, this treatment strategy could improve the efficiency of antibiotic therapeutics and shows great potential in the treatment of S. xylosus infections. John Wiley and Sons Inc. 2021-06-28 /pmc/articles/PMC8867972/ /pubmed/34180582 http://dx.doi.org/10.1111/1751-7915.13870 Text en © 2021 The Authors. Microbial Biotechnology published by Society for Applied Microbiology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Zheng, Si‐Di
Zhang, Zhi‐Yun
Ma, Jin‐Xin
Qu, Qian‐Wei
God'spowe, Bello‐Onaghise
Qin, Yue
Chen, Xue‐Ying
Li, LU
Zhou, Dong‐Fang
Ding, Wen‐Ya
Li, Yan‐Hua
CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection
title CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection
title_full CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection
title_fullStr CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection
title_full_unstemmed CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection
title_short CD‐g‐CS nanoparticles for enhanced antibiotic treatment of Staphylococcus xylosus infection
title_sort cd‐g‐cs nanoparticles for enhanced antibiotic treatment of staphylococcus xylosus infection
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867972/
https://www.ncbi.nlm.nih.gov/pubmed/34180582
http://dx.doi.org/10.1111/1751-7915.13870
work_keys_str_mv AT zhengsidi cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT zhangzhiyun cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT majinxin cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT quqianwei cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT godspowebelloonaghise cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT qinyue cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT chenxueying cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT lilu cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT zhoudongfang cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT dingwenya cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection
AT liyanhua cdgcsnanoparticlesforenhancedantibiotictreatmentofstaphylococcusxylosusinfection